[DOI] [PMC free article] [PubMed] [Google Scholar] 59.Subedi L., Lee S.E., Madiha S., Gaire B.P., Jin M., Yumnam S., Kim S.Y
Overall GLP-1 prescribing rates (GLP-1 RA prescriptions per total prescriptions) in September 2025 remained stable relative to June 2025 (+4.6%)
Patients with genetic variants associated with robust GLP1R signaling, for example, may achieve target weight loss at lower doses with fewer side effects, while others benefit from more gradual dose escalation or combination therapy with tirzepatide
Monitor Your Health Regularly check your blood sugar levels and monitor for any side effects
Target-based drug discovery: is something wrong
Funding This work was supported by the National Science and Technology Council, Taiwan (grant number NSTC 1122314B650001MY3) and E-Da Hospital (EDAHP114016, EDAHS114019, EDAHJ113006, EDAHJ114008)